Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease

Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease

Nonalcoholic fatty liver disease (NAFLD) currently represents one of the most common liver diseases worldwide. Early diagnosis and disease staging is crucial, since it is mainly asymptomatic, but can progress to nonalcoholic steatohepatitis (NASH) or cirrhosis or even lead to the development of hepa...

Full description

Bibliographic Details
Main Authors: Georgiana-Emmanuela Gîlcă-Blanariu, Daniela Simona Budur, Dana Elena Mitrică, Elena Gologan, Oana Timofte, Gheorghe Gh Bălan, Vasile Andrei Olteanu, Gabriela Ștefănescu
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Metabolites
Subjects:
biomarkers
nonalcoholic fatty liver disease
nonalcoholic steatohepatitis
markers
serological markers
fibrosis
Online Access:https://www.mdpi.com/2218-1989/13/11/1115

Internet

https://www.mdpi.com/2218-1989/13/11/1115

Similar Items